Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117955) titled 'Platelet-Rich Plasma for Peyronie's Disease' on Aug. 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Herlev Hospital

Condition: Peyronies Disease

Intervention: Other: Autologous Platelet Rich Plasma

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: September 20, 2025

Target Sample Size: 84

Countries of Recruitment: Denmark

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07117955

Disclaimer: Curated by HT Syndication....